821-17-0

Basic information

• Product Name: Oleic acid 3-hydroxypropyl ester
• Synonyms: (Z)-9-Octadecenoic acid 3-hydroxypropyl ester;Oleic acid 3-hydroxypropyl ester
• CAS NO: 821-17-0
• Molecular Formula: C₂₁H₄₀O₃
• Molecular Weight: 340.54
• Mol File: 821-17-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Oleic acid 3-hydroxypropyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Oleic acid 3-hydroxypropyl ester(821-17-0)
• EPA Substance Registry System: Oleic acid 3-hydroxypropyl ester(821-17-0)

Safety Data

• Hazardous Substances Data: 821-17-0(Hazardous Substances Data)

Upstream product

• 112-77-6 (Z)-9-octadecenoyl chloride 
• 504-63-2 trimethyleneglycol 
• 213738-49-9 C₄₀H₅₄O₃ 
• 112-80-1 cis-Octadecenoic acid 
• 627-30-5 1-chloro-3-hydroxypropane 

Downstream Products

• 244073-65-2 1-(3-propyloleoate)thiophosphate 
• 183323-34-4 (Z)-Octadec-9-enoic acid 3-(bis-benzyloxy-phosphoryloxy)-propyl ester 

Relevant articles and documents

Fatty acid monomer, preparation method and thermoplastic macromolecule synthesized through application

The invention discloses a fatty acid monomer, a preparation method and a thermoplastic macromolecule synthesized through application. Tetramethyl guanidine and other catalysts are mainly utilized to catalyze a monomer containing halogen elements (Cl, Br and I) or halogen element and fatty acid, and the fatty acid monomer and thermoplastic macromolecule are obtained through efficient reaction. The application range can be thus widened by functionally improving the obtained fatty acid monomer and thermoplastic macromolecule. The reaction process is mild in condition, the catalytic efficiency of the catalysts is very high, few side reactions is produced, products are easy to separate and purify, and the fatty acid monomer and the thermoplastic macromolecule have a very high industrial application prospect.

Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof

The present invention provides therapeutic compositions containing lysophosphotidic acids, methods for making the compositions, and methods of using the compositions in the preservation and treatment of organs.

Facile synthesis of lysophospholipids containing unsaturated fatty acid chains

The efficient synthesis of polyunsaturated phospholipids is challenging due to the sensitivity of the unsaturated moiety to the conditions employed in phosphate ester deprotection. We discuss here three independent methods that resolve this issue and enable the synthesis of a series of unsaturated lysophosphatidic acid mimics for the development of a more comprehensive understanding of the structure-activity relationship in this series.